There was one company in a city associated with Faulkner County that received FDA citations as a result of one inspection conducted in the county in 2025, according to the U.S. Food and Drug Administration (FDA).
This is unchanged from the number of companies cited in the previous year.
The citations in the county include:
- Employees engaged in the manufacture and processing of a drug product lack the training and experience required to perform their assigned functions.
- Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
- Control procedures are not established which validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product.
The company cited was involved in the Drugs sector.
The company cited had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Company Name | Area of Business | Inspection Date | Issue Cited |
|---|---|---|---|
| Turbare Manufacturing | Drugs | 01/24/2025 | Training , Education , Experience overall |
| Turbare Manufacturing | Drugs | 01/24/2025 | Absence of Written Procedures |
| Turbare Manufacturing | Drugs | 01/24/2025 | Control procedures to monitor and validate performance |
| Turbare Manufacturing | Drugs | 01/24/2025 | Procedures for sterile drug products |
| Turbare Manufacturing | Drugs | 01/24/2025 | Validation lacking for sterile drug products |
| Turbare Manufacturing | Drugs | 01/24/2025 | Acceptance criteria for sampling & testing |
| Turbare Manufacturing | Drugs | 01/24/2025 | Investigations of discrepancies, failures |
| Turbare Manufacturing | Drugs | 01/24/2025 | Second person sign off |
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



